Show PDB file:   
         Plain Text   HTML   (compressed file size)
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(-)Asymmetric Unit
(-)Asym. Unit - sites
(-)Biological Unit 1
(-)Biol. Unit 1 - sites
(-)Biological Unit 2
collapse expand < >
Image Asymmetric Unit
Asymmetric Unit  (Jmol Viewer)
Image Asym. Unit - sites
Asym. Unit - sites  (Jmol Viewer)
Image Biological Unit 1
Biological Unit 1  (Jmol Viewer)
Image Biol. Unit 1 - sites
Biol. Unit 1 - sites  (Jmol Viewer)
Image Biological Unit 2
Biological Unit 2  (Jmol Viewer)

(-) Description

Title :  PH DOMAIN AND BTK MOTIF FROM BRUTON'S TYROSINE KINASE MUTANT E41K IN COMPLEX WITH INS(1,3,4,5)P4
 
Authors :  K. Djinovic Carugo, E. Baraldi, M. Hyvoenen, P. Lo Surdo, A. Riley, B. M. Saraste
Date :  25 Sep 98  (Deposition) - 15 Jun 99  (Release) - 13 Jul 11  (Revision)
Method :  X-RAY DIFFRACTION
Resolution :  2.10
Chains :  Asym. Unit :  A,B
Biol. Unit 1:  A,B  (2x)
Biol. Unit 2:  A,B  (2x)
Keywords :  Transferase, Ph Domain, Btk Motif, Inositol-(1, 3, 4, 5)- Tetrakisphosphate, Zinc Binding, X-Linked Agammaglobulinemia, Tyrosine-Protein Kinase (Keyword Search: [Gene Ontology, PubMed, Web (Google))
 
Reference :  E. Baraldi, K. D. Carugo, M. Hyvonen, P. L. Surdo, A. M. Riley, B. V. Potter, R. O'Brien, J. E. Ladbury, M. Saraste
Structure Of The Ph Domain From Bruton'S Tyrosine Kinase In Complex With Inositol 1, 3, 4, 5-Tetrakisphosphate.
Structure Fold. Des. V. 7 449 1999
PubMed-ID: 10196129  |  Reference-DOI: 10.1016/S0969-2126(99)80057-4

(-) Compounds

Molecule 1 - BRUTON'S TYROSINE KINASE
    CellB-LYMPHOCYTE
    Cell LineBL21
    ChainsA, B
    EC Number2.7.1.112
    EngineeredYES
    Expression SystemESCHERICHIA COLI BL21(DE3)
    Expression System PlasmidPBAT4-BTK3E41K
    Expression System StrainBL21 (DE3)
    Expression System Taxid469008
    Expression System VectorPBAT4
    FragmentPH DOMAIN AND BTK MOTIF
    MutationYES
    Organism CommonHUMAN
    Organism ScientificHOMO SAPIENS
    Organism Taxid9606
    SynonymBRUTON'S AGAMMAGLOBULINEMIA TYROSINE KINASE, BTK

 Structural Features

(-) Chains, Units

  12
Asymmetric Unit AB
Biological Unit 1 (2x)AB
Biological Unit 2 (2x)AB

Summary Information (see also Sequences/Alignments below)

(-) Ligands, Modified Residues, Ions  (2, 6)

Asymmetric Unit (2, 6)
No.NameCountTypeFull Name
14IP4Ligand/IonINOSITOL-(1,3,4,5)-TETRAKISPHOSPHATE
2ZN2Ligand/IonZINC ION
Biological Unit 1 (1, 8)
No.NameCountTypeFull Name
14IP8Ligand/IonINOSITOL-(1,3,4,5)-TETRAKISPHOSPHATE
2ZN-1Ligand/IonZINC ION
Biological Unit 2 (1, 8)
No.NameCountTypeFull Name
14IP8Ligand/IonINOSITOL-(1,3,4,5)-TETRAKISPHOSPHATE
2ZN-1Ligand/IonZINC ION

(-) Sites  (8, 8)

Asymmetric Unit (8, 8)
No.NameEvidenceResiduesDescription
1AC1SOFTWAREHIS A:143 , CYS A:154 , CYS A:155 , CYS A:165BINDING SITE FOR RESIDUE ZN A 171
2AC2SOFTWAREHIS B:143 , CYS B:154 , CYS B:155 , CYS B:165BINDING SITE FOR RESIDUE ZN B 171
3AC3SOFTWARELYS A:12 , SER A:14 , GLN A:15 , GLN A:16 , LYS A:17 , LYS A:18 , SER A:21 , PRO A:22 , ASN A:24 , LYS A:26 , ARG A:28 , TYR A:39 , LYS A:53 , 4IP A:172 , HOH A:187 , HOH A:195 , HOH A:196 , HOH A:222 , HOH A:251 , HOH A:261 , HOH A:271 , HOH A:338BINDING SITE FOR RESIDUE 4IP A 1
4AC4SOFTWARE4IP A:1 , LYS A:26 , ARG A:28 , LYS A:41 , SER A:51 , LYS A:53 , HOH A:196 , HOH A:222 , HOH A:260 , GLU B:45BINDING SITE FOR RESIDUE 4IP A 172
5AC5SOFTWARELYS B:12 , SER B:14 , GLN B:15 , GLN B:16 , LYS B:17 , LYS B:18 , SER B:21 , PRO B:22 , ASN B:24 , ARG B:28 , TYR B:39 , LYS B:53 , 4IP B:172 , HOH B:174 , HOH B:192 , HOH B:196 , HOH B:200 , HOH B:204 , HOH B:225 , HOH B:252BINDING SITE FOR RESIDUE 4IP B 1
6AC6SOFTWAREGLU A:45 , 4IP B:1 , LYS B:26 , ARG B:28 , LYS B:41 , SER B:51 , LYS B:53 , HOH B:179 , HOH B:254 , HOH B:268BINDING SITE FOR RESIDUE 4IP B 172
7ZN1UNKNOWNZN A:171 , HIS A:143 , CYS A:154 , CYS A:155 , CYS A:165ZN BINDING SITE IN THE BTK MOTIF, CHAIN A
8ZN2UNKNOWNZN B:171 , HIS B:143 , CYS B:154 , CYS B:155 , CYS B:165ZN BINDING SITE IN THE BTK MOTIF, CHAIN B

(-) SS Bonds  (0, 0)

(no "SS Bond" information available for 1BWN)

(-) Cis Peptide Bonds  (0, 0)

(no "Cis Peptide Bond" information available for 1BWN)

 Sequence-Structure Mapping

(-) SAPs(SNPs)/Variants  (24, 47)

Asymmetric Unit (24, 47)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
01UniProtVAR_006216L11PBTK_HUMANDisease (XLA)  ---A/BL11P
02UniProtVAR_006217K12RBTK_HUMANDisease (XLA)  ---A/BK12R
03UniProtVAR_006218S14FBTK_HUMANDisease (XLA)  ---A/BS14F
04UniProtVAR_008291K19EBTK_HUMANDisease (XLA)  ---A/BK19E
05UniProtVAR_006219F25SBTK_HUMANDisease (XLA)  ---A/BF25S
06UniProtVAR_008292K27RBTK_HUMANDisease (XLA)  ---A/BK27R
07UniProtVAR_008293R28CBTK_HUMANDisease (XLA)  ---A/BR28C
08UniProtVAR_006220R28HBTK_HUMANDisease (XLA)128620185A/BR28H
09UniProtVAR_006221R28PBTK_HUMANDisease (XLA)  ---A/BR28P
10UniProtVAR_006222T33PBTK_HUMANDisease (XLA)128620189A/BT33P
11UniProtVAR_008960Y39SBTK_HUMANDisease (XLA)  ---A/BY39S
12UniProtVAR_008294Y40CBTK_HUMANDisease (XLA)  ---A/BY40C
13UniProtVAR_008295Y40NBTK_HUMANDisease (XLA)  ---A/BY40N
14UniProtVAR_008296I61NBTK_HUMANDisease (XLA)  ---A/BI61N
15UniProtVAR_008297V64DBTK_HUMANDisease (XLA)  ---A/BV64D
16UniProtVAR_006223V64FBTK_HUMANDisease (XLA)  ---A/BV64F
17UniProtVAR_041676R82KBTK_HUMANPolymorphism56035945AR82K
18UniProtVAR_006225V113DBTK_HUMANDisease (XLA)128621190A/BV113D
19UniProtVAR_008298S115FBTK_HUMANDisease (XLA)  ---A/BS115F
20UniProtVAR_008299T117PBTK_HUMANDisease (XLA)  ---A/BT117P
21UniProtVAR_008300Q127HBTK_HUMANDisease (XLA)  ---A/BQ127H
22UniProtVAR_008301C154SBTK_HUMANDisease (XLA)  ---A/BC154S
23UniProtVAR_008302C155GBTK_HUMANDisease (XLA)  ---A/BC155G
24UniProtVAR_008303C155RBTK_HUMANDisease (XLA)  ---A/BC155R

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)
Biological Unit 1 (24, 94)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
01UniProtVAR_006216L11PBTK_HUMANDisease (XLA)  ---A/BL11P
02UniProtVAR_006217K12RBTK_HUMANDisease (XLA)  ---A/BK12R
03UniProtVAR_006218S14FBTK_HUMANDisease (XLA)  ---A/BS14F
04UniProtVAR_008291K19EBTK_HUMANDisease (XLA)  ---A/BK19E
05UniProtVAR_006219F25SBTK_HUMANDisease (XLA)  ---A/BF25S
06UniProtVAR_008292K27RBTK_HUMANDisease (XLA)  ---A/BK27R
07UniProtVAR_008293R28CBTK_HUMANDisease (XLA)  ---A/BR28C
08UniProtVAR_006220R28HBTK_HUMANDisease (XLA)128620185A/BR28H
09UniProtVAR_006221R28PBTK_HUMANDisease (XLA)  ---A/BR28P
10UniProtVAR_006222T33PBTK_HUMANDisease (XLA)128620189A/BT33P
11UniProtVAR_008960Y39SBTK_HUMANDisease (XLA)  ---A/BY39S
12UniProtVAR_008294Y40CBTK_HUMANDisease (XLA)  ---A/BY40C
13UniProtVAR_008295Y40NBTK_HUMANDisease (XLA)  ---A/BY40N
14UniProtVAR_008296I61NBTK_HUMANDisease (XLA)  ---A/BI61N
15UniProtVAR_008297V64DBTK_HUMANDisease (XLA)  ---A/BV64D
16UniProtVAR_006223V64FBTK_HUMANDisease (XLA)  ---A/BV64F
17UniProtVAR_041676R82KBTK_HUMANPolymorphism56035945AR82K
18UniProtVAR_006225V113DBTK_HUMANDisease (XLA)128621190A/BV113D
19UniProtVAR_008298S115FBTK_HUMANDisease (XLA)  ---A/BS115F
20UniProtVAR_008299T117PBTK_HUMANDisease (XLA)  ---A/BT117P
21UniProtVAR_008300Q127HBTK_HUMANDisease (XLA)  ---A/BQ127H
22UniProtVAR_008301C154SBTK_HUMANDisease (XLA)  ---A/BC154S
23UniProtVAR_008302C155GBTK_HUMANDisease (XLA)  ---A/BC155G
24UniProtVAR_008303C155RBTK_HUMANDisease (XLA)  ---A/BC155R

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)
Biological Unit 2 (24, 94)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
01UniProtVAR_006216L11PBTK_HUMANDisease (XLA)  ---A/BL11P
02UniProtVAR_006217K12RBTK_HUMANDisease (XLA)  ---A/BK12R
03UniProtVAR_006218S14FBTK_HUMANDisease (XLA)  ---A/BS14F
04UniProtVAR_008291K19EBTK_HUMANDisease (XLA)  ---A/BK19E
05UniProtVAR_006219F25SBTK_HUMANDisease (XLA)  ---A/BF25S
06UniProtVAR_008292K27RBTK_HUMANDisease (XLA)  ---A/BK27R
07UniProtVAR_008293R28CBTK_HUMANDisease (XLA)  ---A/BR28C
08UniProtVAR_006220R28HBTK_HUMANDisease (XLA)128620185A/BR28H
09UniProtVAR_006221R28PBTK_HUMANDisease (XLA)  ---A/BR28P
10UniProtVAR_006222T33PBTK_HUMANDisease (XLA)128620189A/BT33P
11UniProtVAR_008960Y39SBTK_HUMANDisease (XLA)  ---A/BY39S
12UniProtVAR_008294Y40CBTK_HUMANDisease (XLA)  ---A/BY40C
13UniProtVAR_008295Y40NBTK_HUMANDisease (XLA)  ---A/BY40N
14UniProtVAR_008296I61NBTK_HUMANDisease (XLA)  ---A/BI61N
15UniProtVAR_008297V64DBTK_HUMANDisease (XLA)  ---A/BV64D
16UniProtVAR_006223V64FBTK_HUMANDisease (XLA)  ---A/BV64F
17UniProtVAR_041676R82KBTK_HUMANPolymorphism56035945AR82K
18UniProtVAR_006225V113DBTK_HUMANDisease (XLA)128621190A/BV113D
19UniProtVAR_008298S115FBTK_HUMANDisease (XLA)  ---A/BS115F
20UniProtVAR_008299T117PBTK_HUMANDisease (XLA)  ---A/BT117P
21UniProtVAR_008300Q127HBTK_HUMANDisease (XLA)  ---A/BQ127H
22UniProtVAR_008301C154SBTK_HUMANDisease (XLA)  ---A/BC154S
23UniProtVAR_008302C155GBTK_HUMANDisease (XLA)  ---A/BC155G
24UniProtVAR_008303C155RBTK_HUMANDisease (XLA)  ---A/BC155R

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

(-) PROSITE Motifs  (2, 4)

Asymmetric Unit (2, 4)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1PH_DOMAINPS50003 PH domain profile.BTK_HUMAN3-133
 
  2A:3-133
B:3-133
2ZF_BTKPS51113 Zinc finger Btk-type profile.BTK_HUMAN135-171
 
  2A:135-170
B:135-170
Biological Unit 1 (2, 8)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1PH_DOMAINPS50003 PH domain profile.BTK_HUMAN3-133
 
  4A:3-133
B:3-133
2ZF_BTKPS51113 Zinc finger Btk-type profile.BTK_HUMAN135-171
 
  4A:135-170
B:135-170
Biological Unit 2 (2, 8)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1PH_DOMAINPS50003 PH domain profile.BTK_HUMAN3-133
 
  4A:3-133
B:3-133
2ZF_BTKPS51113 Zinc finger Btk-type profile.BTK_HUMAN135-171
 
  4A:135-170
B:135-170

(-) Exons   (5, 10)

Asymmetric Unit (5, 10)
 ENSEMBLUniProtKBPDB
No.Transcript IDExonExon IDGenome LocationLengthIDLocationLengthCountLocationLength
1.1bENST000003087311bENSE00001821870X:100641183-100641050134BTK_HUMAN-00--
1.3ENST000003087313ENSE00002149458X:100630302-100630132171BTK_HUMAN1-47472A:2-47
B:2-47
46
46
1.4aENST000003087314aENSE00001643950X:100629622-10062952499BTK_HUMAN48-80332A:48-80
B:48-79
33
32
1.5ENST000003087315ENSE00001646803X:100626689-10062662169BTK_HUMAN81-103232A:81-103 (gaps)
B:88-103
23
16
1.6ENST000003087316ENSE00001698702X:100625067-10062498682BTK_HUMAN104-131282A:104-131
B:104-131
28
28
1.7bENST000003087317bENSE00001643964X:100617677-100617549129BTK_HUMAN131-174442A:131-170
B:131-170
40
40
1.8bENST000003087318bENSE00001601394X:100617228-10061716168BTK_HUMAN174-196230--
1.9ENST000003087319ENSE00001608013X:100615743-100615556188BTK_HUMAN197-259630--
1.10ENST0000030873110ENSE00001712685X:100615138-10061507663BTK_HUMAN259-280220--
1.11ENST0000030873111ENSE00001801955X:100614335-10061428155BTK_HUMAN280-298190--
1.12ENST0000030873112ENSE00000673984X:100613684-10061360580BTK_HUMAN299-325270--
1.13bENST0000030873113bENSE00000673983X:100613425-100613298128BTK_HUMAN325-368440--
1.14bENST0000030873114bENSE00000673982X:100612571-10061249775BTK_HUMAN368-393260--
1.15aENST0000030873115aENSE00000673981X:100611943-100611772172BTK_HUMAN393-450580--
1.16bENST0000030873116bENSE00000673980X:100611256-100611040217BTK_HUMAN450-522730--
1.17ENST0000030873117ENSE00000673977X:100609682-10060961865BTK_HUMAN523-544220--
1.18bENST0000030873118bENSE00001780523X:100608976-100608858119BTK_HUMAN544-584410--
1.19bENST0000030873119bENSE00001702496X:100608339-100608182158BTK_HUMAN584-636530--
1.20bENST0000030873120bENSE00001855631X:100604944-100604438507BTK_HUMAN637-659230--

(-) Sequences/Alignments

Asymmetric Unit
   Reformat: Number of residues per line =  ('0' or empty: single-line sequence representation)
  Number of residues per labelling interval =   
  UniProt sequence: complete  aligned part    
   Show mapping: SCOP domains CATH domains Pfam domains Secondary structure (by author)
SAPs(SNPs) PROSITE motifs Exons
(details for a mapped element are shown in a popup box when the mouse pointer rests over it)
Chain A from PDB  Type:PROTEIN  Length:166
 aligned with BTK_HUMAN | Q06187 from UniProtKB/Swiss-Prot  Length:659

    Alignment length:169
                                    11        21        31        41        51        61        71        81        91       101       111       121       131       141       151       161         
            BTK_HUMAN     2 AAVILESIFLKRSQQKKKTSPLNFKKRLFLLTVHKLSYYEYDFERGRRGSKKGSIDVEKITCVETVVPEKNPPPERQIPRRGEESSEMEQISIIERFPYPFQVVYDEGPLYVFSPTEELRKRWIHQLKNVIRYNSDLVQKYHPCFWIDGQYLCCSQTAKNAMGCQILEN 170
               SCOP domains d1bwna_ A: Bruton's tyrosine kinase                                                                                                                                       SCOP domains
               CATH domains 1bwnA00 A:2-170 Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding dom   ain (PTB)                                                                            CATH domains
               Pfam domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ....eeeeeeee...........eeeeeeee...eeeee...........eeeeeehhheeeeee........hhh......---.hhhhhhhh....eeeeeee...eeeeee..hhhhhhhhhhhhhhh...................................... Sec.struct. author
             SAPs(SNPs) (1) ---------PR-F----E-----S-RC----P-----SC--------------------N--D-----------------K------------------------------D-F-P---------H--------------------------SG--------------- SAPs(SNPs) (1)
             SAPs(SNPs) (2) --------------------------H-----------N-----------------------F------------------------------------------------------------------------------------------R--------------- SAPs(SNPs) (2)
             SAPs(SNPs) (3) --------------------------P---------------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs) (3)
                    PROSITE -PH_DOMAIN  PDB: A:3-133 UniProt: 3-133                                                                                             -ZF_BTK  PDB: A:135-170               PROSITE
           Transcript 1 (1) Exon 1.3  PDB: A:2-47 UniProt: 1-47           Exon 1.4a  PDB: A:48-80          Exon 1.5               Exon 1.6  PDB: A:104-131    --------------------------------------- Transcript 1 (1)
           Transcript 1 (2) ---------------------------------------------------------------------------------------------------------------------------------Exon 1.7b  PDB: A:131-170 [INCOMPLETE]   Transcript 1 (2)
                 1bwn A   2 AAVILESIFLKRSQQKKKTSPLNFKKRLFLLTVHKLSYYKYDFERGRRGSKKGSIDVEKITCVETVVPEKNPPPERQIPRRG---SEMEQISIIERFPYPFQVVYDEGPLYVFSPTEELRKRWIHQLKNVIRYNSDLVQKYHPCFWIDGQYLCCSQTAKNAMGCQILEN 170
                                    11        21        31        41        51        61        71        81 |   |  91       101       111       121       131       141       151       161         
                                                                                                            83  87                                                                                   

Chain B from PDB  Type:PROTEIN  Length:161
 aligned with BTK_HUMAN | Q06187 from UniProtKB/Swiss-Prot  Length:659

    Alignment length:169
                                    11        21        31        41        51        61        71        81        91       101       111       121       131       141       151       161         
            BTK_HUMAN     2 AAVILESIFLKRSQQKKKTSPLNFKKRLFLLTVHKLSYYEYDFERGRRGSKKGSIDVEKITCVETVVPEKNPPPERQIPRRGEESSEMEQISIIERFPYPFQVVYDEGPLYVFSPTEELRKRWIHQLKNVIRYNSDLVQKYHPCFWIDGQYLCCSQTAKNAMGCQILEN 170
               SCOP domains d1bwnb_ B: Bruton's tyrosine kinase                                                                                                                                       SCOP domains
               CATH domains 1bwnB00 B:2-170 Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding         domain (PTB)                                                                       CATH domains
               Pfam domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ....eeeeeeee...........eeeeeeee...eeeee...........eeeeeehhheeeeee........hhh..--------.hhhhhhh....eeeeeee..eeeeeee..hhhhhhhhhhhhhhh...................................... Sec.struct. author
             SAPs(SNPs) (1) ---------PR-F----E-----S-RC----P-----SC--------------------N--D------------------------------------------------D-F-P---------H--------------------------SG--------------- SAPs(SNPs) (1)
             SAPs(SNPs) (2) --------------------------H-----------N-----------------------F------------------------------------------------------------------------------------------R--------------- SAPs(SNPs) (2)
             SAPs(SNPs) (3) --------------------------P---------------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs) (3)
                    PROSITE -PH_DOMAIN  PDB: B:3-133 UniProt: 3-133                                                                                             -ZF_BTK  PDB: B:135-170               PROSITE
           Transcript 1 (1) Exon 1.3  PDB: B:2-47 UniProt: 1-47           Exon 1.4a  PDB: B:48-79          Exon 1.5  PDB: B:88-103Exon 1.6  PDB: B:104-131    --------------------------------------- Transcript 1 (1)
           Transcript 1 (2) ---------------------------------------------------------------------------------------------------------------------------------Exon 1.7b  PDB: B:131-170 [INCOMPLETE]   Transcript 1 (2)
                 1bwn B   2 AAVILESIFLKRSQQKKKTSPLNFKKRLFLLTVHKLSYYKYDFERGRRGSKKGSIDVEKITCVETVVPEKNPPPERQI--------EMEQISIIERFPYPFQVVYDEGPLYVFSPTEELRKRWIHQLKNVIRYNSDLVQKYHPCFWIDGQYLCCSQTAKNAMGCQILEN 170
                                    11        21        31        41        51        61        71       | -      | 91       101       111       121       131       141       151       161         
                                                                                                        79       88                                                                                  

   Legend:   → Mismatch (orange background)
  - → Gap (green background, '-', border residues have a numbering label)
    → Modified Residue (blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
  x → Chemical Group (purple background, 'x', labelled with number + name, e.g. ACE or NH2)
  extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '|'

 Classification and Annotation

(-) SCOP Domains  (1, 2)

Asymmetric Unit

(-) CATH Domains  (1, 2)

Asymmetric Unit
(-)
Class: Mainly Beta (13760)

(-) Pfam Domains  (0, 0)

(no "Pfam Domain" information available for 1BWN)

(-) Gene Ontology  (49, 49)

Asymmetric Unit(hide GO term definitions)
Chain A,B   (BTK_HUMAN | Q06187)
molecular function
    GO:0005524    ATP binding    Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
    GO:0042802    identical protein binding    Interacting selectively and non-covalently with an identical protein or proteins.
    GO:0016301    kinase activity    Catalysis of the transfer of a phosphate group, usually from ATP, to a substrate molecule.
    GO:0008289    lipid binding    Interacting selectively and non-covalently with a lipid.
    GO:0046872    metal ion binding    Interacting selectively and non-covalently with any metal ion.
    GO:0004715    non-membrane spanning protein tyrosine kinase activity    Catalysis of the reaction: ATP + protein L-tyrosine = ADP + protein L-tyrosine phosphate by a non-membrane spanning protein.
    GO:0000166    nucleotide binding    Interacting selectively and non-covalently with a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose or deoxyribose.
    GO:0005547    phosphatidylinositol-3,4,5-trisphosphate binding    Interacting selectively and non-covalently with phosphatidylinositol-3,4,5-trisphosphate, a derivative of phosphatidylinositol in which the inositol ring is phosphorylated at the 3', 4' and 5' positions.
    GO:0005515    protein binding    Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
    GO:0004672    protein kinase activity    Catalysis of the phosphorylation of an amino acid residue in a protein, usually according to the reaction: a protein + ATP = a phosphoprotein + ADP.
    GO:0004713    protein tyrosine kinase activity    Catalysis of the reaction: ATP + a protein tyrosine = ADP + protein tyrosine phosphate.
    GO:0005102    receptor binding    Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
    GO:0016740    transferase activity    Catalysis of the transfer of a group, e.g. a methyl group, glycosyl group, acyl group, phosphorus-containing, or other groups, from one compound (generally regarded as the donor) to another compound (generally regarded as the acceptor). Transferase is the systematic name for any enzyme of EC class 2.
biological process
    GO:0042113    B cell activation    The change in morphology and behavior of a mature or immature B cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific.
    GO:0050853    B cell receptor signaling pathway    A series of molecular signals initiated by the cross-linking of an antigen receptor on a B cell.
    GO:0038095    Fc-epsilon receptor signaling pathway    A series of molecular signals initiated by the binding of the Fc portion of immunoglobulin E (IgE) to an Fc-epsilon receptor on the surface of a signal-receiving cell, and ending with regulation of a downstream cellular process, e.g. transcription. The Fc portion of an immunoglobulin is its C-terminal constant region.
    GO:0007249    I-kappaB kinase/NF-kappaB signaling    The process in which a signal is passed on to downstream components within the cell through the I-kappaB-kinase (IKK)-dependent activation of NF-kappaB. The cascade begins with activation of a trimeric IKK complex (consisting of catalytic kinase subunits IKKalpha and/or IKKbeta, and the regulatory scaffold protein NEMO) and ends with the regulation of transcription of target genes by NF-kappaB. In a resting state, NF-kappaB dimers are bound to I-kappaB proteins, sequestering NF-kappaB in the cytoplasm. Phosphorylation of I-kappaB targets I-kappaB for ubiquitination and proteasomal degradation, thus releasing the NF-kappaB dimers, which can translocate to the nucleus to bind DNA and regulate transcription.
    GO:0002755    MyD88-dependent toll-like receptor signaling pathway    Any series of molecular signals generated as a consequence of binding to a toll-like receptor where the MyD88 adaptor molecule mediates transduction of the signal. Toll-like receptors directly bind pattern motifs from a variety of microbial sources to initiate innate immune response.
    GO:0002250    adaptive immune response    An immune response mediated by cells expressing specific receptors for antigen produced through a somatic diversification process, and allowing for an enhanced secondary response to subsequent exposures to the same antigen (immunological memory).
    GO:0006915    apoptotic process    A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died.
    GO:0097190    apoptotic signaling pathway    A series of molecular signals which triggers the apoptotic death of a cell. The pathway starts with reception of a signal, and ends when the execution phase of apoptosis is triggered.
    GO:0019722    calcium-mediated signaling    Any intracellular signal transduction in which the signal is passed on within the cell via calcium ions.
    GO:0048469    cell maturation    A developmental process, independent of morphogenetic (shape) change, that is required for a cell to attain its fully functional state.
    GO:0002376    immune system process    Any process involved in the development or functioning of the immune system, an organismal system for calibrated responses to potential internal or invasive threats.
    GO:0045087    innate immune response    Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens.
    GO:0035556    intracellular signal transduction    The process in which a signal is passed on to downstream components within the cell, which become activated themselves to further propagate the signal and finally trigger a change in the function or state of the cell.
    GO:0007498    mesoderm development    The process whose specific outcome is the progression of the mesoderm over time, from its formation to the mature structure. The mesoderm is the middle germ layer that develops into muscle, bone, cartilage, blood and connective tissue.
    GO:0001818    negative regulation of cytokine production    Any process that stops, prevents, or reduces the rate of production of a cytokine.
    GO:0038083    peptidyl-tyrosine autophosphorylation    The phosphorylation by a protein of one or more of its own tyrosine amino acid residues, or a tyrosine residue on an identical protein.
    GO:0018108    peptidyl-tyrosine phosphorylation    The phosphorylation of peptidyl-tyrosine to form peptidyl-O4'-phospho-L-tyrosine.
    GO:0016310    phosphorylation    The process of introducing a phosphate group into a molecule, usually with the formation of a phosphoric ester, a phosphoric anhydride or a phosphoric amide.
    GO:0045579    positive regulation of B cell differentiation    Any process that activates or increases the frequency, rate or extent of B cell differentiation.
    GO:0051092    positive regulation of NF-kappaB transcription factor activity    Any process that activates or increases the frequency, rate or extent of activity of the transcription factor NF-kappaB.
    GO:0006468    protein phosphorylation    The process of introducing a phosphate group on to a protein.
    GO:0002902    regulation of B cell apoptotic process    Any process that modulates the frequency, rate, or extent of B cell apoptotic process.
    GO:0002721    regulation of B cell cytokine production    Any process that modulates the frequency, rate, or extent of B cell cytokine production.
    GO:0042127    regulation of cell proliferation    Any process that modulates the frequency, rate or extent of cell proliferation.
    GO:0006355    regulation of transcription, DNA-templated    Any process that modulates the frequency, rate or extent of cellular DNA-templated transcription.
    GO:0006351    transcription, DNA-templated    The cellular synthesis of RNA on a template of DNA.
    GO:0007169    transmembrane receptor protein tyrosine kinase signaling pathway    A series of molecular signals initiated by the binding of an extracellular ligand to a receptor on the surface of the target cell where the receptor possesses tyrosine kinase activity, and ending with regulation of a downstream cellular process, e.g. transcription.
cellular component
    GO:0005737    cytoplasm    All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
    GO:0031410    cytoplasmic vesicle    A vesicle found in the cytoplasm of a cell.
    GO:0005829    cytosol    The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
    GO:0031234    extrinsic component of cytoplasmic side of plasma membrane    The component of a plasma membrane consisting of gene products and protein complexes that are loosely bound to its cytoplasmic surface, but not integrated into the hydrophobic region.
    GO:0043231    intracellular membrane-bounded organelle    Organized structure of distinctive morphology and function, bounded by a single or double lipid bilayer membrane and occurring within the cell. Includes the nucleus, mitochondria, plastids, vacuoles, and vesicles. Excludes the plasma membrane.
    GO:0016020    membrane    A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
    GO:0045121    membrane raft    Any of the small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions.
    GO:0005634    nucleus    A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
    GO:0005886    plasma membrane    The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

 Visualization

(-) Interactive Views

Asymmetric Unit
  Complete Structure
    Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
    WebMol | AstexViewer[tm]@PDBe
(Java Applets, require no local installation except for Java; loading may be slow)
    STRAP
(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    RasMol
(require local installation)
    Molscript (VRML)
(requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)
 
  Ligands, Modified Residues, Ions
    4IP  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    ZN  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
 
  Sites
    AC1  [ RasMol ]  +environment [ RasMol ]
    AC2  [ RasMol ]  +environment [ RasMol ]
    AC3  [ RasMol ]  +environment [ RasMol ]
    AC4  [ RasMol ]  +environment [ RasMol ]
    AC5  [ RasMol ]  +environment [ RasMol ]
    AC6  [ RasMol ]  +environment [ RasMol ]
    ZN1  [ RasMol ]  +environment [ RasMol ]
    ZN2  [ RasMol ]  +environment [ RasMol ]
 
  Cis Peptide Bonds
(no "Cis Peptide Bonds" information available for 1bwn)
 
Biological Units
  Complete Structure
    Biological Unit 1  [ Jena3D ]
    Biological Unit 2  [ Jena3D ]

(-) Still Images

Jmol
  protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick
Molscript
  protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick

 Databases and Analysis Tools

(-) Databases

Access by PDB/NDB ID
  1bwn
    Family and Domain InformationProDom | SYSTERS
    General Structural InformationGlycoscienceDB | MMDB | NDB | OCA | PDB | PDBe | PDBj | PDBsum | PDBWiki | PQS | PROTEOPEDIA
    Orientation in MembranesOPM
    Protein SurfaceSURFACE
    Secondary StructureDSSP (structure derived) | HSSP (homology derived)
    Structural GenomicsGeneCensus
    Structural NeighboursCE | VAST
    Structure ClassificationCATH | Dali | SCOP
    Validation and Original DataBMRB Data View | BMRB Restraints Grid | EDS | PROCHECK | RECOORD | WHAT_CHECK
 
Access by UniProt ID/Accession number
  BTK_HUMAN | Q06187
    Comparative Protein Structure ModelsModBase
    Genomic InformationEnsembl
    Protein-protein InteractionDIP
    Sequence, Family and Domain InformationInterPro | Pfam | SMART | UniProtKB/SwissProt
 
Access by Enzyme Classificator   (EC Number)
  2.7.1.112
    General Enzyme InformationBRENDA | EC-PDB | Enzyme | IntEnz
    PathwayKEGG | MetaCyc
 
Access by Disease Identifier   (MIM ID)
  300755
    Disease InformationOMIM
 
Access by GenAge ID
  (no 'GenAge ID' available)
    Age Related InformationGenAge

(-) Analysis Tools

Access by PDB/NDB ID
    Domain InformationXDom
    Interatomic Contacts of Structural UnitsCSU
    Ligand-protein ContactsLPC
    Protein CavitiescastP
    Sequence and Secondary StructurePDBCartoon
    Structure AlignmentSTRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    Structure and Sequence BrowserSTING
 
Access by UniProt ID/Accession number
  BTK_HUMAN | Q06187
    Protein Disorder PredictionDisEMBL | FoldIndex | GLOBPLOT (for more information see DisProt)

 Related Entries

(-) Entries Sharing at Least One Protein Chain (UniProt ID)

UniProtKB/Swiss-Prot
        BTK_HUMAN | Q061871aww 1awx 1b55 1btk 1k2p 1qly 2ge9 2z0p 3gen 3k54 3ocs 3oct 3p08 3pix 3piy 3piz 3pj1 3pj2 3pj3 4nwm 4ot5 4ot6 4otf 4otq 4otr 4rfy 4rfz 4rg0 4rx5 4yhf 4z3v 4zly 4zlz 5bpy 5bq0 5fbn 5fbo 5j87 5jrs 5kup 5p9f 5p9g 5p9h 5p9i 5p9j 5p9k 5p9l 5p9m 5t18 5u9d 5vgo

(-) Related Entries Specified in the PDB File

(no "Related Entries Specified in the PDB File" available for 1BWN)